Aurora Cannabis Inc. (ACB) vs Canopy Growth Corporation (CGC)

Aurora Cannabis Inc. and Canopy Growth Corporation are both Drug Manufacturers Specialty & Generic companies. Aurora Cannabis Inc. is the larger, with a market value of $341.2M against $283.5M — 1.2× the size. Canopy Growth Corporation grew revenue faster over the last twelve months: 7.80% against −18.2%. Aurora Cannabis Inc. has the higher net margin (−38.1% vs −80.4%) and the higher return on invested capital (−5.58% vs −17.2%). Across the 18 metrics below, Aurora Cannabis Inc. leads on 12 and Canopy Growth Corporation on 6.

Valuation

Metric ACB CGC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 1.53 1.35 2.08
P/B 0.84 0.58 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 1.28 1.01 2.87
Earnings yield (27.12%) (65.34%) (15.94%)
Free cash flow yield (11.26%) (21.13%) 0.00%

Profitability

Metric ACB CGC Drug Manufacturers Specialty & Generic median
Gross margin 49.74% 25.16% 53.51%
Operating margin (12.13%) (54.89%) 0.00%
Net margin (38.12%) (80.39%) (2.45%)
Free cash flow margin (17.19%) (28.34%) 0.00%
Return on equity (19.85%) (40.14%) (0.80%)
Return on assets (15.19%) (23.54%) (1.67%)
Return on invested capital (5.58%) (17.19%) 0.00%

Growth

Metric ACB CGC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (18.18%) 7.80% 5.22%
EPS growth (last fiscal year) (5,266.67%) 84.00% 42.91%
Revenue growth, 5-year CAGR 3.92% (13.04%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACB CGC Drug Manufacturers Specialty & Generic median
Debt to equity 0.03 0.35 0.04
Current ratio 5.36 3.04 2.41
Net debt to EBITDA 5.11 1.09 1.01

Dividend

Metric ACB CGC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ACB CGC Drug Manufacturers Specialty & Generic median
Market cap 341.19m 283.50m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack